Two Sigma Securities, LLC Acadia Pharmaceuticals Inc Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $230,063 - $340,698	-7,269 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $98,346 - $139,602	-2,716 Reduced 27.2%	7,269 $311,000
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $221,866 - $439,439	9,985 New	9,985 $359,000
Q4 2017 Feb 14, 2018	SELL	$26.84 - $39.14 $157,470 - $229,634	-5,867 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $173,017 - $225,116	5,867	5,867 $221,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.68B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.